Mark W. Douglas

机构：The University of Sydney, Westmead Hospital, Infectious Diseases Institute, Westmead Institute, Sydney Local Health District, Westmead Institute for Medical Research, Columbia Theological Seminary · ORCID：0000-0003-4621-3485

发表论文 136 篇 · 总被引 3993 次 · h-index 35

代表论文

• The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune Responses (2025 · Gastroenterology · 被引 32)
• Hepatitis B Virus and Hepatitis C Virus Affect Mitochondrial Function Through Different Metabolic Pathways, Explaining Virus-Specific Clinical Features of Chronic Hepatitis (2024 · The Journal of Infectious Diseases · 被引 18)
• BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial (2024 · Journal of Infection · 被引 14)
• Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial (2025 · Nature Medicine · 被引 12)
• PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus Replication (2023 · International Journal of Molecular Sciences · 被引 10)
• Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants (2024 · EBioMedicine · 被引 8)